Results 211 to 220 of about 2,359,169 (353)

Can CT Measurement of Emphysema Severity Aid Patient Selection for Lung Volume Reduction Surgery? [PDF]

, 2000
Steve H. Salzman
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Treatment of oligometastatic breast cancer: The role of patient selection. [PDF]

Breast
Colciago RR, De Santis MC, Giandini C, Carnevale MG, Di Cosimo S.   +4 more
europepmc   +1 more source

Is transcranial colour Duplex flow imaging of use in selection of patients with acute stroke for thrombolysis? [PDF]

, 2000
G. Devuyst
openalex   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Transcatheter Tricuspid Regurgitation Repair-An Overview of Techniques and Eligible Patient Selection. [PDF]

J Clin Med
Mustafa ER, Marinescu D, Florescu C, Donoiu I, Istrătoaie O.   +4 more
europepmc   +1 more source

PATIENT SELECTION FOR ADULT COCHLEAR IMPLANTATION AND ITS EXPERIENCE

, 1993
Mikiko Fukiyama, Koji Matsuura
openalex   +2 more sources

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Seminal vesicle biopsy and laparoscopic pelvic lymph node dissections implications for patient selection in the radiotherapeutic management of prostate cancer

, 1994
Nelsnn Stone, Richard G. Stock, Pam Unger   +2 more
openalex   +1 more source

Use of Patient-Derived Human Immunodeficiency Virus Type 1 Integrases To Identify a Protein Residue That Affects Target Site Selection [PDF]

, 2001
Amy L. Harper, Lynn M. Skinner, Malgorzata Sudol, Michael Katzman   +3 more
openalex   +1 more source